Dong Sung Bio Pharm.Co.,Ltd. (KRX:002210)
4,110.00
+10.00 (0.24%)
Feb 7, 2025, 9:00 AM KST
KRX:002210 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | 2006 - 2005 |
---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 6, 2025 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | 2006 - 2005 |
Market Capitalization | 89,063 | 24,633 | 24,810 | 26,238 | 21,826 | 36,502 | Upgrade
|
Market Cap Growth | 13.52% | -0.71% | -5.45% | 20.22% | -40.21% | 54.87% | Upgrade
|
Enterprise Value | 40,658 | 40,658 | 42,182 | 43,804 | 36,221 | 56,080 | Upgrade
|
Last Close Price | 3895.00 | 1371.34 | 1351.36 | 1359.95 | 1080.35 | 1914.43 | Upgrade
|
PE Ratio | 40.43 | 14.48 | - | 46.16 | 5.97 | 13.74 | Upgrade
|
PS Ratio | 0.88 | 0.31 | 0.34 | 0.38 | 0.35 | 0.61 | Upgrade
|
PB Ratio | 1.14 | 0.41 | 0.42 | 0.39 | 0.32 | 0.79 | Upgrade
|
P/TBV Ratio | 0.42 | 0.42 | 0.43 | 0.39 | 0.33 | 0.79 | Upgrade
|
P/FCF Ratio | - | - | 8.74 | - | - | 30.36 | Upgrade
|
P/OCF Ratio | - | - | 6.73 | - | - | 12.51 | Upgrade
|
EV/Sales Ratio | 0.52 | 0.52 | 0.59 | 0.64 | 0.58 | 0.93 | Upgrade
|
EV/EBITDA Ratio | 8.82 | 8.82 | - | 18.10 | 12.61 | 18.56 | Upgrade
|
EV/EBIT Ratio | 13.10 | 13.10 | - | 39.66 | 24.38 | 36.05 | Upgrade
|
EV/FCF Ratio | - | - | 14.87 | - | - | 46.65 | Upgrade
|
Debt / Equity Ratio | 0.58 | 0.58 | 0.57 | 0.46 | 0.40 | 0.68 | Upgrade
|
Debt / EBITDA Ratio | 7.57 | 7.57 | - | 12.93 | 9.42 | 10.39 | Upgrade
|
Debt / FCF Ratio | - | - | 11.87 | - | - | 26.10 | Upgrade
|
Asset Turnover | 0.62 | 0.62 | 0.56 | 0.54 | 0.55 | 0.60 | Upgrade
|
Inventory Turnover | 3.06 | 3.06 | 2.83 | 2.47 | 2.49 | 2.42 | Upgrade
|
Quick Ratio | 1.18 | 1.18 | 1.20 | 1.39 | 1.61 | 1.49 | Upgrade
|
Current Ratio | 1.47 | 1.47 | 1.45 | 1.74 | 2.02 | 1.81 | Upgrade
|
Return on Equity (ROE) | 2.85% | 2.85% | -12.36% | 0.84% | 6.42% | 6.04% | Upgrade
|
Return on Assets (ROA) | 1.54% | 1.54% | -1.52% | 0.55% | 0.81% | 0.96% | Upgrade
|
Return on Capital (ROIC) | 2.06% | 2.06% | -2.02% | 0.71% | 1.08% | 1.29% | Upgrade
|
Return on Capital Employed (ROCE) | 4.21% | 4.21% | - | 1.31% | 1.68% | 2.42% | Upgrade
|
Earnings Yield | 1.91% | 6.91% | -31.66% | 2.17% | 16.75% | 7.28% | Upgrade
|
FCF Yield | -3.40% | -12.28% | 11.44% | -21.89% | -3.58% | 3.29% | Upgrade
|
Dividend Yield | 2.19% | 2.19% | - | 2.21% | 2.78% | 1.57% | Upgrade
|
Payout Ratio | 31.14% | 31.14% | - | 95.83% | 14.90% | 25.81% | Upgrade
|
Buyback Yield / Dilution | 2.59% | 1.98% | 0.79% | - | -4.39% | 11.41% | Upgrade
|
Total Shareholder Return | 2.59% | 4.17% | 0.79% | 2.21% | -1.61% | 12.98% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.